Continuous Femoral Nerve Blockade and Readiness to Discharge Following Total Knee Arthroplasty

NCT00803348 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Knee Arthroplasty

Interventions

DRUG: Bolus of 0.2% ropivicaine 20 mls followed by 0.2% ropivicaine at an infusion rate of 5mls/hr until 0600 on postoperative day 2
DRUG: Bolus of 0.2% ropivicaine 20 mls followed by 0.1% ropivicaine at an infusion rate of 10mls/hr until 0600 on post-operative day 2
DRUG: Saline control

Sponsor

University Health Network, Toronto